SABBY 13G LIXT 3.03.21

Company

LIXTE BIOTECHNOLOGY HOLDINGS, INC.

Filed

March 3, 2021

Accession Number

0001535610-21-000083

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →